在现实环境中使用罗提古丁的安全性:使用FAERS数据的药监测研究
Jiakuan Tu1,2, Chaoxiang Zhang1,2, Yichun Qiu1,2
1The First Department of Orthopedics, Jiangxi Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Nanchang, 33003, China.
BMC pharmacology & toxicology
|April 1, 2025
概括
这项研究使用FDA数据分析了罗提古丁的不良反应,发现了产品粘附问题和意外的严重事件,如跌倒和帕金森病. 持续的营销后监测对于患者的安全至关重要.
科学领域:
- 药监和药物安全 药监和药物安全
- 神经学和运动障碍 神经学和运动障碍
- 制药科学 制药科学
背景情况:
- 评估使用FDA不良事件报告系统 (FAERS) 自发报告对罗提古丁的不良反应.
- 为优化临床剂量策略提供关键的见解.
研究的目的:
- 通过分析自发性不良事件报告来评估罗提古丁的安全性.
- 为了识别和描述与使用罗提古丁相关的不良事件 (AE).
主要方法:
- 从2007年第二季度到2024年第二季度的FAERS数据的回顾性分析.
- 使用了四种不成比例分析方法:报告几率比率 (ROR),比例报告比率 (PRR),贝叶斯信心传播神经网络 (BCPNN) 和多项性马鱼收缩 (MGPS).
主要成果:
- 分析了超过1750万份FAERS报告中的7,570份与罗提古丁相关的AE报告.
- 确定了172个具有显著不成比例的首选术语 (PT),包括产品粘附问题 (主要AE),药物无效性,跌倒事件和帕金森病.
- 到AE发作的中位时间为213天,事件发生在30天内和治疗后360天.
结论:
- 这些发现与罗提古丁已知的安全概况一致.
- 揭示了意想不到的严重不良事件,强调需要持续监测.
- 强调在营销后对罗提古丁的监测中持续保持警的重要性.
相关概念视频
Pharmacovigilance
755
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
755
Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
Drug Administration and Therapy Phases: Overview
391
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
391
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
212
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
212


